Balancing Analgesia and Life-Saving Therapy in Pediatric Oncology: A Case of Chemotherapy-Induced Neuropathy
Document Type
Conference Proceeding
Publication Date
10-18-2026
Abstract
A 13-year-old female patient with rhabdomyosarcoma experienced chemotherapy-induced peripheral neuropathy (CIPN) and severe pain secondary to vincristine. During treatment, her mother requested delay of her chemotherapy and augmentation of her analgesia regimen due to symptom burden. This case highlights the ethical challenges of balancing adequate pain control with the obligation to provide life-saving treatment in pediatric populations who are unable to consent independently. We will review ethical considerations surrounding treatment continuation in the setting of uncontrolled pain, the role of parental decision-making, and the application of patient assent in decisions regarding essential chemotherapy.
Recommended Citation
Manna Z, Soto R, Kitchen S. Balancing analgesia and life-saving therapy in pediatric oncology: a case of chemotherapy-induced neuropathy. Presented at: American Society of Anesthesiologists, The Anesthesiology Meeting; 2026 Oct 18; San Diego, CA. Available from: https://www.abstractsonline.com/pp8/#!/21448/presentation/9202
Comments
American Society of Anesthesiologists, The Anesthesiology Meeting, October 16-20, 2026, San Diego, CA